We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Messe Düsseldorf Promotes International “MEDICAlliance” Portfolio at ADLM 2024

By LabMedica International staff writers
Posted on 31 Jul 2024

Messe Düsseldorf (Düsseldorf, Germany) is participating in the ADLM Clinical Lab Expo 2024 to promote its “MEDICAlliance” program of regional and international medical trade fairs organized around the globe. More...

At ADLM booth 4421, visitor and exhibitor information are available for MEDICA 2024, World Forum for Medicine, and COMPAMED 2024, high-tech solutions for medical technology (held currently from November 11 – 14, 2024 in Düsseldorf, Germany), Medical Fair China (August 2024 in Suzhou), Medical Fair Asia and Medical Manufacturing Asia (held concurrently in September 2024 in Singapore) as well as Medical Fair Thailand (September 2025 in Bangkok) and Medical Fair India (2025 in New Delhi).

With over 5,300 exhibitors from almost 70 countries and 83,000 visitors from around the globe, MEDICA in Düsseldorf is one of the largest medical B2B trade fairs in the world. The event presents a wide range of innovative products and services from the fields of medical imaging, laboratory technology, diagnostics, health IT, and mobile health as well as physiotherapy/orthopedic technology and medical consumables. The exhibitors showcase innovations along the industry's entire value chain and for the complete workflow of modern healthcare. The extensive program of forums, conferences, and special shows complement the exhibits. On average, 800+ international IVD companies and lab equipment manufacturers have participated each year, displaying the latest global advancements in laboratory medicine, equipment, and molecular diagnostic solutions.

Related Links:
Messe Düsseldorf


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
Gold Member
POCT RT-qPCR Analyzer
BG-X6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.